RABIH FAHED, M.D.
Hematology & Oncology Physician · NORFOLK, NE
Individual Active NPI 1043488844
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 847 | 258,876 | $17,353,446 | $6,774,472 | $5,392,608 |
| 2023 | 888 | 311,377 | $20,240,524 | $7,342,121 | $5,821,617 |
| 2022 | 878 | 319,900 | $18,100,461 | $6,366,578 | $5,059,011 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9263 | Injection, oxaliplatin, 0.5 mg | 22,940 | $0 | $0 |
| Q5125 | Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 18,180 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 16,800 | $56 | $45 |
| J0897 | Injection, denosumab, 1 mg | 14,940 | $26 | $21 |
| J0185 | Injection, aprepitant, 1 mg | 12,740 | $2 | $1 |
| J9267 | Injection, paclitaxel, 1 mg | 11,110 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,690 | $3 | $2 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,600 | $20 | $16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,110 | $0 | $0 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 2,150 | $4 | $4 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,070 | $1 | $1 |
| J9190 | Injection, fluorouracil, 500 mg | 1,661 | $3 | $2 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 24944 | NE |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Nebraska
- NPI 1255404091
- NPI 1346313186
- NPI 1891347886
- NPI 1568556314
- NPI 1225366628
- NPI 1164412425
- NPI 1053301317
- NPI 1124076997
See all Hematology & Oncology Physician providers in Nebraska →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.